Clinical Trials Browser

Carcinoma × relatlimab × 90 days × Clear all

NCT05347212 2026-04-15

Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

Phase 2 Active not recruiting

Carcinoma